Skip to main content

Advertisement

SpringerLink
Log in

Diabetic ketoacidosis in acromegaly: a case study—somatostatin analogs adverse event or disease complication?

  • Case Report
  • Published:
Acta Diabetologica Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Ferraù F, Albani A, Ciresi A, Giordano C, Cannavò S (2018) Diabetes secondary to acromegaly: physiopathology, clinical features and effects of treatment. Front Endocrinol. https://doi.org/10.3389/fendo.2018.00358

    Article  Google Scholar 

  2. Vergès B (2017) Effects of anti-somatostatin agents on glucose metabolism. Diabetes Metab 43(5):411–415. https://doi.org/10.1016/j.diabet.2017.05.003

    Article  CAS  PubMed  Google Scholar 

  3. Shimon I, Adnan Z, Gorshtein A et al (2018) Efficacy and safety of long-acting pasireotide in patients with somatostatin-resistant acromegaly: a multicenter study. Endocrine. https://doi.org/10.1007/s12020-018-1690-5

    Article  PubMed  Google Scholar 

  4. Colao A, Bronstein MD, Freda P et al (2014) Pasireotide versus octreotide in acromegaly: a head-to-head superiority study. J Clin Endocrinol Metab 99(3):791–799. https://doi.org/10.1210/jc.2013-2480

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Samson SL (2016) Management of hyperglycemia in patients with acromegaly treated with pasireotide LAR. Drugs 76(13):1235–1243. https://doi.org/10.1007/s40265-016-0615-y

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The authors would like to thank their patient for giving the consent to the publication of her medical history.

Author information

Authors and Affiliations

  1. Division of Endocrinology, Diabetology and Metabolism, Department of Medical Science, University Hospital “Città della Salute e della Scienza di Torino”, Corso Dogliotti 14, 10126, Turin, Italy

    Nunzia Prencipe, Fabio Bioletto, Chiara Bona, Filippo Gatti & Silvia Grottoli

Authors
  1. Nunzia Prencipe
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Fabio Bioletto
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Chiara Bona
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Filippo Gatti
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Silvia Grottoli
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nunzia Prencipe.

Ethics declarations

Conflict of interest

All the authors declare that they have nothing to disclose and no conflict of interest.

Ethical approval

The case-study has been reported in accordance with the Principles of Declaration of Helsinki.

Informed consent

The person involved in this case-study gave informed consent prior to her inclusion. Details that might disclose the identity of the subject have been omitted.

Additional information

Managed by Antonio Secchi.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Prencipe, N., Bioletto, F., Bona, C. et al. Diabetic ketoacidosis in acromegaly: a case study—somatostatin analogs adverse event or disease complication?. Acta Diabetol 57, 491–493 (2020). https://doi.org/10.1007/s00592-019-01437-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00592-019-01437-z

Search

Navigation